New Study on Home AED Use Raises Potential Benefits of Wearable Defibrilators

Unique Treatment Option for Those at Risk of Sudden Cardiac Arrest Offers Patients Constant Monitoring, Immediate Protection Regardless of Bystander/Caregiver Presence

A unique, non-invasive technology may provide a solution.
LifeVest(R), an FDA-approved wearable defibrillator manufactured by
ZOLL Medical Corporation has been worn by nearly 9,000 patients
with a high risk of sudden cardiac arrest and serves as a solution
for patients who go into SCA, even while unwitnessed. To date, the
LifeVest has treated patients in SCA without requiring bystander
intervention 150 times, with a 99% first shock success rate.

WHO: The following key opinion leaders are available for immediate
comment:

Richard A. Packer Ranjit Suri M.D.
President and CEO Director, Cardiac Arrhythmia Service
ZOLL Medical Corp. Cardiac Arrhythmia Center
New York Hospital Queens
Weil Medical College of Cornell Univ.

CONTACT: Tara DiMilia Diane Egan
Office: 908-369-7168 Office: 978-421-9637
Cell: 908-884-7024 Cell: 508-740-2102

PRNewswire -- April 1, 2008

Source: ZOLL Medical Corporation

2008-04-01 17:01:06 0325548 PRNEWSWIRE